register

News & Trends - MedTech & Diagnostics

Varian and Lung Foundation Australia shed light on optimal use of radiation therapy in cancer care journey

Health Industry Hub | November 24, 2022 |

MedTech News: Navigating the care pathway from cancer diagnosis is complex for most Australians. Radiation therapy (RT) is one of the pillars of cancer therapy, however, despite advances in contemporary RT many patients are not treated with RT.

Rebecca Cortiula, Senior Managing Director Australasia, Varian and Mark Brooke, CEO of Lung Foundation Australia joined Health Industry Hub to discuss the joint whitepaper – Shining a light: Radiotherapy cancer treatment in Australia – launched in Parliament House yesterday.

According to the whitepaper, RT has a role in curing 40% of all cancers. Unfortunately, 20% of cancer patients who should receive RT in line with best practice care do not receive it.

Ms Cortiula and Mr Brooke reflected on the improvements in equity of care required so that all cancer patients eligible to receive RT are offered this efficacious treatment option that is also economically sound. In fact, for every dollar of tax payer funds invested in treating cancer, RT costs only 6 cents.

“We’ve come to that point now as a patient advocacy community where we expect the gold standard because that’s what we’re paying for with our taxpayer dollars. These are treatments that should be available to people but tragically are not,” said Mr Brooke.

Ms Cortiula commented on leveraging digital technologies to reduce the equity gaps for supporting remote and rural communities. She said “We have made huge leaps forward with digital health during this [pandemic] period. So the location of the specialist shouldn’t impact the ability for them to support a patient.”

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Federal Health Minister succumbs to pressure, commits to extra meeting to clear PBAC backlog

Federal Health Minister succumbs to pressure, commits to extra meeting to clear PBAC backlog

Health Industry Hub | November 7, 2024 |

Pharma News: The Minister for Health and Aged Care, Mark Butler MP, has confirmed that the Pharmaceutical Benefits Advisory Committee […]

More


News & Trends - MedTech & Diagnostics

Medtech company partners with Aussie researchers in AI technology for GI cancer detection

Medtech company partners with Aussie researchers in AI technology for GI cancer detection

Health Industry Hub | November 7, 2024 |

MedTech & Diagnostics News: To develop a next-generation gastrointestinal (GI) flexible endomicroscope equipped with edge-artificial intelligence (AI) technology, Monash University’s […]

More


News & Trends - Pharmaceuticals

Local oncologists first to enrol prostate cancer patients in phase 3 theranostics trial

Local oncologists first to enrol prostate cancer patients in phase 3 theranostics trial

Health Industry Hub | November 7, 2024 |

Pharma News: GenesisCare oncologists have achieved a significant milestone, becoming the first to enrol and deliver patient treatment in a […]

More


Human Resources

Ipsen's culture of 'collaboration and diversity' earns Great Place to Work certification

Ipsen’s culture of ‘collaboration and diversity’ earns Great Place to Work certification

Health Industry Hub | November 6, 2024 |

Ipsen Australia and New Zealand has announced its certification as a Great Place to Work in 2024, joining 11 other […]

More


This content is copyright protected. Please subscribe to gain access.